Peptide Synthesis Industry Worth $859 million by 2028, with a CAGR of 7.4%
The report "Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid), Services, End User (Pharma, Biotech, CRO), Region - Global Forecast to 2028", is projected to USD 859 million by 2028 from USD 601 million in 2023, at a CAGR of 7.4% between 2023 and 2028.
Browse 238 market data Tables and 41 Figures spread through 257 Pages and in-depth TOC on "Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid), Services, End User (Pharma, Biotech, CRO), Region - Global Forecast to 2028"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/peptide-synthesis-market-158927365.html
The global peptide synthesis market is expected to grow at a CAGR of 7.4% during the forecast period. Growth in this market is driven by the increasing demand for peptide, technological advancements in peptide synthesis and expanding therapeutic applications. Furthermore, rising investment in research and development, and a supportive market ecosystem, use of peptides in pharmaceutical drugs are some of major elements anticipated spur the market growth. However, the lack of a unified set of regulations for therapeutic peptides and the high cost of instruments are expected to restrain the growth of this market during the forecast period.
The reagents segment accounted for the largest share of the product & service segment in the peptide synthesis market in 2022.
Based on product & service, the peptide synthesis market is segmented into reagents, equipment, and services. In 2022, the reagents segment accounted for the largest share of the peptide synthesis market. The large share of this segment is fueled by the increasing demand for peptide-based therapeutics, advancements in synthesis technologies, expanding research and development activities, the rise of contract research and manufacturing organizations, and the availability of various peptide synthesis reagents in the market.
The Solid Phase peptide synthesis segment accounted for the largest share of the technology segment in the peptide synthesis market in 2022.
Based on technology, the peptide synthesis market is segmented into solid-phase peptide synthesis, solution-phase peptide synthesis, and hybrid & recombinant technology. The solid-phase peptide synthesis segment accounted for the largest share in the peptide synthesis market in 2022. Solid-phase peptide synthesis is associated offers various advantages such as ease of operation, easy purification, short production cycles, high-level automation, and synthesis capabilities of long peptides in small quantities of amino acids. These advantages support the growth of the solid-phase peptide synthesis segment.
Asia Pacific is likely to grow at the highest growth rate during the forecast period.
Based on the region, peptide synthesis market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America is the largest regional segment. The Asia Pacific region is estimated to grow at the highest CAGR in the peptide synthesis market during the forecast period. The growth of the pharmaceuticals and life sciences market in the region is primarily driven by the rising R&D expenditure, especially in the area of drug discovery & development, the rising prevalence of chronic disease conditions, and significant investments in the development of therapeutics mAbs.
The prominent players operating in the peptide synthesis market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Kaneka Corporation (Japan), GenScript Biotech Corporation (China), and Bachem Holding AG (Switzerland).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Peptide Synthesis Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
